Next Article in Journal
New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials
Previous Article in Journal
An Improved Synthesis of 7, 8-Epoxy-1,3,11-cembratriene-15R(α), 16-diol, a Cembranoid of Marine Origin with a Potent Cancer Chemopreventive Activity
Article Menu

Export Article

Open AccessArticle
Mar. Drugs 2004, 2(1), 8-13; doi:10.3390/md201008

Antifungal Activity of (+)-Curcuphenol, a Metabolite from the Marine Sponge Didiscus oxeata

Instituto Nacional de Engenharia e Tecnologia Industrial, Estrada do Paço do Lumiar, 1649-038, Lisboa, Portugal
Institute for Biodiversity and Ecosystem Dynamics, University of Amsterdam, P.O. Box 94766, 1090-GT, Netherlands
Author to whom correspondence should be addressed.
Received: 17 October 2003 / Accepted: 26 November 2003 / Published: 25 February 2004
View Full-Text   |   Download PDF [35 KB, uploaded 24 February 2015]   |  


The antifungal activity of the sesquiterpenoids (+)-curcuphenol and (+)-curcudiol isolated from the Caribbean sponge Didiscus oxeata was evaluated against several filamentous fungi. View Full-Text
Keywords: Porifera; Didiscus oxeata; antifungal; curcuphenol; curcudiol Porifera; Didiscus oxeata; antifungal; curcuphenol; curcudiol

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Gaspar, H.; Feio, S.S.; Rodrigues, A.I.; Van Soest, R. Antifungal Activity of (+)-Curcuphenol, a Metabolite from the Marine Sponge Didiscus oxeata. Mar. Drugs 2004, 2, 8-13.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top